Non-invasive Brain Stimulation in Multiple Sclerosis Fatigue
Recruiting
N/A
Interventional Study
Multiple Sclerosis
Fatigue in Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 84 (estimated)
- Sponsor
- Charite University, Berlin, Germany · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The neurobiological basis of central fatigue in multiple sclerosis remained unclear so far. This study investigates reward-related brain mechanisms, inflammation, and their modulation by non-invasive brain stimulation using fMRI, proteomics, and clinical measures to improve future treatment of central fatigue in MS. In the study, persons suffering from relapsing-remitting MS (RRMS) with vs. withou…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women
* 18 - 70 years
* Established MS diagnosis (relapsing-remitting MS; RRMS) prior to study inclusion
* Maximal EDSS of 4
* Maximal disease duration 10 years
* Existing health insurance
* Stable or no treatment with disease modifying treatment (DMT) in …
Contacts